| Year |
Citation |
Score |
| 2023 |
Zhang L, Cui S, Ding N, Zhang J, Cui E, Xiang Q, Zhou Z, Sun B, Wang Y, Hong H, Ma Y, Yang D. Tumor-Associated Macrophages Regulating a Polymer Nanoplatform for Synergistic Treatment of Breast Tumors. Acs Applied Materials & Interfaces. PMID 37462215 DOI: 10.1021/acsami.3c05497 |
0.306 |
|
| 2022 |
Chen J, Liu G, Wang X, Hong H, Li T, Li L, Wang H, Xie J, Li B, Li T, Lu D, Zhang Y, Zhao H, Yao C, Wen K, et al. Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling. Cell Stem Cell. PMID 36265493 DOI: 10.1016/j.stem.2022.09.009 |
0.324 |
|
| 2021 |
Yu XP, Wang L, Yu HY, Zou YW, Wang C, Jiao JW, Hong H, Zhang S. MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors. Cancer Management and Research. 13: 329-336. PMID 33488120 DOI: 10.2147/CMAR.S284220 |
0.355 |
|
| 2021 |
Yu XP, Wang L, Yu HY, Zou YW, Wang C, Jiao JW, Hong H, Zhang S. MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors. Cancer Management and Research. 13: 329-336. PMID 33488120 DOI: 10.2147/CMAR.S284220 |
0.355 |
|
| 2019 |
Xu C, Nam J, Hong H, Xu Y, Moon JJ. Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy. Acs Nano. PMID 31556987 DOI: 10.1021/acsnano.9b06691 |
0.331 |
|
| 2016 |
Yang D, Feng L, Dougherty CA, Luker KE, Chen D, Cauble MA, Banaszak Holl MM, Luker GD, Ross BD, Liu Z, Hong H. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide. Biomaterials. 104: 361-371. PMID 27490486 DOI: 10.1016/J.Biomaterials.2016.07.029 |
0.302 |
|
| 2016 |
Hong H, Brown CE, Ostberg JR, Priceman SJ, Chang WC, Weng L, Lin P, Wakabayashi MT, Jensen MC, Forman SJ. L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice. Plos One. 11: e0146885. PMID 26761817 DOI: 10.1371/journal.pone.0146885 |
0.435 |
|
| 2015 |
Hong H, Yan Y, Shi S, Graves SA, Krasteva LK, Nickles RJ, Yang M, Cai W. PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging. Molecular Pharmaceutics. 12: 403-10. PMID 25581441 DOI: 10.1021/Mp500766X |
0.307 |
|
| 2014 |
Wen W, Liang W, Wu J, Kowolik CM, Buettner R, Scuto A, Hsieh MY, Hong H, Brown CE, Forman SJ, Horne D, Morgan R, Wakabayashi M, Dellinger TH, Han ES, et al. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer. Molecular Cancer Therapeutics. 13: 3037-48. PMID 25319391 DOI: 10.1158/1535-7163.Mct-14-0077 |
0.448 |
|
| 2011 |
Liu Y, Punj V, Hong H, Enbom E, Maxson R, Dubeau L. Abstract 2395: Effect of Brca1 knockout on gene expression in mouse ovarian granulosa cells Cancer Research. 71: 2395-2395. DOI: 10.1158/1538-7445.Am2011-2395 |
0.63 |
|
| 2010 |
Hong H, Yang Y, Zhang Y, Cai W. Non-invasive cell tracking in cancer and cancer therapy. Current Topics in Medicinal Chemistry. 10: 1237-1248. PMID 20388105 DOI: 10.2174/156802610791384234 |
0.325 |
|
| 2010 |
Hong H, Yen HY, Brockmeyer A, Liu Y, Chodankar R, Pike MC, Stanczyk FZ, Maxson R, Dubeau L. Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Research. 70: 221-8. PMID 20028858 DOI: 10.1158/0008-5472.Can-09-3232 |
0.58 |
|
| 2005 |
Chodankar R, Kwang S, Sangiorgi F, Hong H, Yen HY, Deng C, Pike MC, Shuler CF, Maxson R, Dubeau L. Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Current Biology : Cb. 15: 561-5. PMID 15797026 DOI: 10.1016/J.Cub.2005.01.052 |
0.586 |
|
| Show low-probability matches. |